Influenza vaccination recommended for all adults aged 50 years and older, United States

International Congress Series

Volumn 1219, Issue C, 2001, Pages 665-669

  Strikas, Raymond A ^a   Bridges, Carolyn B ^b   Singleton, James A ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Adults 50 years and older; Influenza vaccine; United States

Indexed keywords

EID: 84864535820     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00670-7     Document Type: Article

References (19)

1. CDC. Influenza Surveillance Report No. 80. U.S. Department of Health Education, and Welfare, Public Health Service, Atlanta, GA, 1964, pp. 8–11.
2. CDC. Recommendations of the public health service advisory committee on immunization practices: Influenza. MMWR, 23, 1974, 215.
3. CDC. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices. MMWR 49:No. RR-3 (2000), 1–38.
4. Ambrosch, F., Fedson, D.S., Influenza vaccination in 29 countries. An update to 1997. Pharmacoeconomics 16:Suppl. 1 (1999), 47–54.
5. Fedson, D.S., Adult immunization: summary of the national vaccine advisory committee report. JAMA, J. Am. Med. Assoc. 272 (1994), 1133–1137.
6. Nichol, K.L., Lind, A., Margolis, K.L., et al. The effectiveness of vaccination against influenza in healthy, working adults. N. Engl. J. Med. 333 (1995), 889–893.
7. Wilde, J.A., McMillan, J.A., Serwint, J., Butta, J., O'Riordan, M.A., Steinhoff, M.C., Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA, J. Am. Med. Assoc. 281 (1999), 908–913.
8. Campbell, D.S., Rumley, M.H., Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J. Occup. Environ. Med. 39 (1997), 408–414.
9. Smith, J.W.G., Pollard, R., Vaccination against influenza: a five-year study in the post office. J. Hyg. 83 (1979), 157–170.
10. Bridges, C.B., Thompson, W.W., Meltzer, M.I., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized placebo controlled study. JAMA, J. Am. Med. Assoc. 284 (2000), 1655–1663.
11. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd edn., 1996, Williams & Wilkins, Baltimore.
12. CDC. Notice to readers: assessing adult vaccination status at age 50 years. MMWR 44 (1995), 561–563.
13. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am. J. Prev. Med. 8:Supplement 1 (2000), 92–96.
14. CDC. Notice to readers: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000–01 influenza season. MMWR 49 (2000), 619–622.
15. Barker, Wh., Mullooly, J.P., Impact of epidemic type A influenza in a defined adult population. Am. J. Epidemiol. 112 (1980), 798–811.
16. Glezen, W.P., Decker, M., Perrotta, D.M., Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978–1981. Am. Rev. Respir. Dis. 136 (1987), 550–555.
17. Glezen, W.P., Influenza surveillance in an urban area. Can. J. Infect. Dis. 4 (1993), 272–274.
18. CDC. Influenza and pneumococcal vaccination coverage levels among persons ≥65 years-United States, 1973–1993. MMWR 1995; 44: pp. 506–7, 513–15.
19. Walker, F.J., Singleton, J.A., Lu, P.J., Strikas, R.A., Influenza vaccination of healthcare workers in the United States 1989–97. Infect. Control Hosp. Epidemiol., 21, 2000, 113.